MNMD  221118C00002500

Sold MNMD $2.50 Calls

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Rod Alzmann

MNMD  221021C00003000

Sold MNMD $3 Calls

MNMD  221021C00012500

Bought all MNMD $12.50 Calls

MNMD  221021C00002500

Sold MNMD $12.50 Calls

MNMD  220916C00001000

Sold MNMD $1 Calls

MNMD  220916C00002000

Sold MNMD $2 Calls

MNMD  221216C00000500

Sold all MNMD $0.50 Calls

MNMD  221216C00001000

Sold all MNMD $1 Calls

Bought MNMD $0.50 Calls

Bought MNMD $1 Calls

MNMD  240119C00002500

Sold all MNMD $2.50 Calls

Abilash Satya

Taylor Daniel

Bought 120% of MNMD $2.50 Calls

Bought MNMD $2.50 Calls

MNMD  230120C00002500

MNMD  220617C00002500

MNMD  220318C00002500

Michael Paradise

Mind Medicine Inc., also known as MindMed, is a New York-based psychedelic medicine biotech company that develops psychedelic-inspired medicines known as psychoplastogens and therapies to address addiction and mental illness.

Mind Medicine (MindMed) Inc. Common Shares

Sold all MNMD

Adam Barzel

Mike Pelech

New position in MNMD

Bought 9% more MNMD

Miguel Gómez Bravo

Bought 1% more MNMD

Oren Mordechai

Bought 5% more MNMD

Christian Bryant

Todd Feller

Sold 100% of MNMD

Bought 255% more MNMD

Sold 3% of MNMD

Daniel Ruvins

Bought 10% more MNMD

Bought <1% more MNMD

Elisa Esteves

Robert Moore

Bought 344% more MNMD